Kelley RK, Sangro B, Harris W, Ikeda M, et al. Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study. J Clin Oncol 2021 Jul 22:JCO2003555. doi: 10.1200/JCO.20.03555.
PMID: 34292792